BIT

0.00%

1.9¢ biotron limited

MM was the one who used the word 'cure' I think...well, she is a...

First 9342 Last

Share
Profile

Follow
mark12

2,021 Posts.

307

23/01/22

19:36

Post #: 59074453
Share

Originally posted by Footmax: ↑

Great position for BIT to be in.

I have owned biotech shares for 10 years - in fact, BIT was the first biotech share I owned - had 2mil at one stage. Probably involved myself with 12 or so biotech companies over the last decade.

I own shares in just two biotechs now and have basically specialised in the cancer field - one is a pure spec share (interestingly, because of the success in trials with mice which were outstanding. The other I am in fairly deep and they are up to human trials - with cancer now absent in the odd patient after two years.

I originally got enthused with BIT when they announced they had the "cure" for HepC and that they were on the way to doing the same with HIV. They had some toxicity issues but I believed that getting HIV nailed was a great goal - as well as being a chance of getting great profits on my investment. I became jaded and, maybe a bit concerned, that if, the compounds BIT had were so good, why had they not linked up with a partner and why the compounds had not been snapped up for commercialisation.

All biotechs have their red and green flags. If I have one complaint about BIT - and it is the only one - it would be that they "oversell" their products and use the word "cure" way too loosely.

I do think that BIT has a good deal of promise with HIV in particular - still think that gives BIT reason to be taken seriously.

As I alluded to though, COVID is a crowded space. Big pharmas will only get interested with truly spectacular human trial results. Too early to call if BIT will come out in front of the pack with COVID - just too many companies chasing the same thing. I also think that COVID is a side show compared to the serious issue with HIV - and that is not trivialising COVID and its effects in any way.

I do hope that BIT is successful in either of its endeavours.

Expand

MM was the one who used the word 'cure' I think...well, she is a scientist and I have reason to believe her...scientists are prone to be extremely conservative. She was genuinely excited at the time it seemed. MH tempered her a bit from memory. Cat is out of the bag for me though.

BIT Price at posting: 8.2¢ Sentiment: Buy Disclosure: Held
7 Upvote

0 Great analysis

Reply

Top Stories

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

The market's shrugged at China's stimulus measures all year. Why is this one different?

The winners & losers on market if negative gearing were gone

KAL

KalGold rolls out detailed aeromagnetic survey across Pinjin project

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

ESR

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

NAM

ACCC seeks Olam divestments before it can buy Namoi Cotton

STK

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

DEG

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

There are more pages in this discussion • 3,983 more messages in this thread...

First 9342 Last

Add BIT (ASX) to my watchlist

(20min delay)
Last 1.9¢		Change 0.000(0.00%)		Mkt cap ! $17.14M

Open	High	Low	Value	Volume
1.9¢	1.9¢	1.9¢	$7.664K	403.3K

Buyers (Bids)

No.	Vol.	Price($)
1	100000	1.9¢

Sellers (Offers)

Price($)	Vol.	No.
2.0¢	1202498	5

View Market Depth

No.	Vol.	Price($)
1	100000	0.019
10	1774771	0.018
10	1139476	0.017
12	3734154	0.016
10	1205000	0.015

Price($)	Vol.	No.
0.020	1052498	3
0.021	500000	1
0.022	1431102	4
0.023	1100772	2
0.024	153949	2

Last trade - 13.42pm 27/09/2024 (20 minute delay)

BIT (ASX) Chart

MM was the one who used the word 'cure' I think...well, she is a...

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

The market's shrugged at China's stimulus measures all year. Why is this one different?

The winners & losers on market if negative gearing were gone

KalGold rolls out detailed aeromagnetic survey across Pinjin project

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

ACCC seeks Olam divestments before it can buy Namoi Cotton

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

MM was the one who used the word 'cure' I think...well, she is a...

Top Stories

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

The market's shrugged at China's stimulus measures all year. Why is this one different?

The winners & losers on market if negative gearing were gone

KalGold rolls out detailed aeromagnetic survey across Pinjin project

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

ACCC seeks Olam divestments before it can buy Namoi Cotton

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News